Researchers from the Netherlands Institute for Neuroscience (NIN) and the Leiden University Medical Center (LUMC) have shown that treatment using gene therapy leads to a faster recovery after nerve damage.
By combining a surgical repair procedure with gene therapy, the survival of nerve cells and regeneration of nerve fibers over a long distance was stimulated for the first time. The discovery, published in the journal Brain, is an important step towards the development of a new treatment for people with nerve damage.
During birth or following a traffic accident, nerves in the neck can be torn out of the spinal cord. As a result, these patients lose their arm function, and are unable to perform daily activities such as drinking a cup of coffee. Currently, surgical repair is the only available treatment for patients suffering this kind of nerve damage. “After surgery, nerve fibers have to bridge many centimeters before reaching the muscles and nerve cells from which new fibers need to regenerate are lost in large numbers. Most regenerating nerve fiber do not reach the muscles. The recovery of arm function is therefore disappointing and incomplete,” explains researcher Ruben Eggers of the NIN.
COMBINATION OF TREATMENTS
By combining neurosurgical repair with gene therapy in rats, many of the dying nerve cells can be rescued and nerve fiber growth in the direction of the muscle can be stimulated.
In this study, the researchers used regulatable gene therapy with a growth factor that could be switched on and off by using a widely used antibiotic. “Because we were able to switch off the gene therapy when the growth factor was no longer needed, the regeneration of new nerve fibers towards the muscles was improved considerably,” says Ruben Eggers.
A STEALTH GENE SWITCH
To overcome the problem of the immune system recognizing and removing the gene switch, the researchers developed a hidden version, a so-called ‘stealth switch’. Professor Joost Verhaagen (NIN) explains: “The stealth gene switch is an important step forward towards the development of gene therapy for nerve damage. The use of a stealth switch improves the gene therapy rendering it even safer.”
The gene therapy is not yet ready for use in patients. While the ability to switch off a therapeutic gene is a large step forward, the researchers still found small amounts of the active gene when the switch was turned off. Therefore, further research is needed to optimize this therapy.
Learn more: Gene therapy promotes nerve regeneration
The Latest on: Nerve regeneration
via Google News
The Latest on: Nerve regeneration
- Mayo Clinic discovers a molecular switch for repairing central nervous system disorderson January 10, 2020 at 8:10 am
Research by Isobel Scarisbrick, Ph.D., published in the Journal of Neuroscience finds that by genetically switching off a receptor activated by blood proteins, named Protease Activated Receptor 1 ...
- Nerve-healing startup Renerva joins McGovern incubatoron January 9, 2020 at 11:18 am
He is a former Cornell postdoctoral researcher. Millions of people in the U.S. suffer from peripheral nerve injuries or problems, and peripheral nerve regeneration is slow and not always complete, ...
- Nerve Repair And Regeneration Marketon January 8, 2020 at 9:51 am
The research report attempts to offer a comprehensive analysis of the Nerve Repair and Regeneration Market status and development trends, including growth, opportunities, rising technology, ...
- Axogen Sponsored RANGER® Registry Reaches 2,000 Nerve Repair Enrollment Milestoneon January 8, 2020 at 4:01 am
Largest peripheral nerve repair registry in the world generates clinical evidence of repair, safety, and outcomes data for peripheral nerve injuries ...
- Axogen to Participate at AAHS ASPN ASRM 2020 Annual Meetingson January 2, 2020 at 4:23 pm
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced its participation at the combined 2020 ...
- Axogen, Inc. to Participate at JP Morgan 38th Annual Healthcare Conferenceon January 2, 2020 at 3:00 am
About Axogen Axogen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate ...
- AxoGen Working Its Way Out Of The Penalty Box, But Execution Is Keyon December 31, 2019 at 12:03 pm
Clinical data continue to support expanded use of AxoGen's nerve regeneration scaffolds. AxoGen shares look undervalued on their growth potential, but "potential" needs to be backed up with better ...
- Newport Beach Plastic Surgeons Use Cutting Edge Techniques and Principleson December 30, 2019 at 5:35 pm
He himself had worked in the development of new technology and has published the results of his work in renowned journals. His work has dealt with stem cell technology, nerve regeneration, facial ...
- Probabilistic Assessment of Nerve Regeneration with Diffusion MRI in Rat Models of Peripheral Nerve Traumaon December 23, 2019 at 2:06 am
Nerve regeneration after injury must occur in a timely fashion to restore function. Unfortunately, current methods (e.g., electrophysiology) provide limited information following trauma, resulting in ...
- Nerve Regeneration Market Treatment Analysis, Key Players, Industry Size, Growth Factors and Trend Forecast To 2024on December 19, 2019 at 3:07 am
Nerve Regeneration refers to the process of repair and regrowth of injured nerve tissues, cells, and cell products. It is also referred as Neuroregeneration, Large number of cases of nervous system ...
via Bing News